Zynex acquires Kestrel Labs for $31M

71
7
Favorite

Zynex acquires Kestrel Labs for $31M

seekingalpha2021-12-23

Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company. The transaction closed on December 22, 2021 at an approx. value of $31M, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（7）

Yue7
·2021-12-24
Cool
Reply
Like
Report
ckLai
·2021-12-23
Hi
Reply
2
Report
JoshuaLiew
·2021-12-23
Ok
Reply
3
Report
chehe
·2021-12-23
[LOL]
Reply
3
Report
Le66ad
·2021-12-23
🤞🏻
Reply
1
Report
Not_Luke
·2021-12-23
Ooooo
Reply
1
Report
kcdc86
·2021-12-23
Pls like.. Thanks..
Reply
4
Report
Fold Replies
- jub:
  Ok
  2021-12-23
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1122468807?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-12-23 22:15","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1122468807","market":"us","top_or_hot":-1,"title":"Zynex acquires Kestrel Labs for $31M","media":"seekingalpha","content":"<div>\n<p>Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zynex acquires Kestrel Labs for $31M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZynex acquires Kestrel Labs for $31M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZYXI","symbol_name":"Zynex, Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m","article_id":"1122468807","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122468807","pubTimestamp":1640268939,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring t","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ZYXI":"Zynex, Inc."},"translate_title":"Zynex以3100万美元收购Kestrel实验室","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZYXI":0.9},"content_text":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.\nZYXI shares down 1.4% premarket at $10.42.\nKestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).\n\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.\nKestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":698952698,"gmtCreate":1640286479224,"gmtModify":1676532438701,"author":{"id":"3562111968746343","authorId":"3562111968746343","name":"Yue7","avatar":"https://static.tigerbbs.com/eb04a4755e1e2aabf66975d89c053a2e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3562111968746343","idStr":"3562111968746343"},"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/698952698","repostId":1122468807,"repostType":4,"repost":{"id":"1122468807","kind":"news","pubTimestamp":1640268939,"share":"https://ttm.financial/m/news/1122468807?lang=&edition=fundamental","pubTime":"2021-12-23 22:15","market":"us","language":"en","title":"Zynex acquires Kestrel Labs for $31M","url":"https://stock-news.laohu8.com/highlight/detail?id=1122468807","media":"seekingalpha","summary":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring t","content":"<p>Zynex(NASDAQ:ZYXI)has&nbsp;acquired&nbsp;100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.</p>\n<p>The transaction closed on December&nbsp;22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.</p>\n<p>ZYXI shares&nbsp;down 1.4% premarket&nbsp;at $10.42.</p>\n<p>Kestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).</p>\n<p>\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.</p>\n<p>Kestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zynex acquires Kestrel Labs for $31M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZynex acquires Kestrel Labs for $31M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZYXI":"Zynex, Inc."},"source_url":"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1122468807","content_text":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.\nZYXI shares down 1.4% premarket at $10.42.\nKestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).\n\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.\nKestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":9000452714,"gmtCreate":1640272764825,"gmtModify":1676533513780,"author":{"id":"3576459018241155","authorId":"3576459018241155","name":"ckLai","avatar":"https://static.tigerbbs.com/23354f3443d8a51feae4f8b8a4f5458c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3576459018241155","idStr":"3576459018241155"},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000452714","repostId":1122468807,"repostType":4,"repost":{"id":"1122468807","kind":"news","pubTimestamp":1640268939,"share":"https://ttm.financial/m/news/1122468807?lang=&edition=fundamental","pubTime":"2021-12-23 22:15","market":"us","language":"en","title":"Zynex acquires Kestrel Labs for $31M","url":"https://stock-news.laohu8.com/highlight/detail?id=1122468807","media":"seekingalpha","summary":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring t","content":"<p>Zynex(NASDAQ:ZYXI)has&nbsp;acquired&nbsp;100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.</p>\n<p>The transaction closed on December&nbsp;22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.</p>\n<p>ZYXI shares&nbsp;down 1.4% premarket&nbsp;at $10.42.</p>\n<p>Kestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).</p>\n<p>\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.</p>\n<p>Kestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zynex acquires Kestrel Labs for $31M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZynex acquires Kestrel Labs for $31M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZYXI":"Zynex, Inc."},"source_url":"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1122468807","content_text":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.\nZYXI shares down 1.4% premarket at $10.42.\nKestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).\n\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.\nKestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9000453815,"gmtCreate":1640271481756,"gmtModify":1676533513632,"author":{"id":"3559194206832147","authorId":"3559194206832147","name":"JoshuaLiew","avatar":"https://static.tigerbbs.com/b503d223679dec0ab7416f6186269f11","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3559194206832147","idStr":"3559194206832147"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000453815","repostId":1122468807,"repostType":4,"repost":{"id":"1122468807","kind":"news","pubTimestamp":1640268939,"share":"https://ttm.financial/m/news/1122468807?lang=&edition=fundamental","pubTime":"2021-12-23 22:15","market":"us","language":"en","title":"Zynex acquires Kestrel Labs for $31M","url":"https://stock-news.laohu8.com/highlight/detail?id=1122468807","media":"seekingalpha","summary":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring t","content":"<p>Zynex(NASDAQ:ZYXI)has&nbsp;acquired&nbsp;100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.</p>\n<p>The transaction closed on December&nbsp;22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.</p>\n<p>ZYXI shares&nbsp;down 1.4% premarket&nbsp;at $10.42.</p>\n<p>Kestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).</p>\n<p>\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.</p>\n<p>Kestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zynex acquires Kestrel Labs for $31M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZynex acquires Kestrel Labs for $31M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZYXI":"Zynex, Inc."},"source_url":"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1122468807","content_text":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.\nZYXI shares down 1.4% premarket at $10.42.\nKestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).\n\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.\nKestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":698903278,"gmtCreate":1640271084685,"gmtModify":1676532436550,"author":{"id":"3566095201042840","authorId":"3566095201042840","name":"chehe","avatar":"https://community-static.tradeup.com/news/9ace7f1bb53f41394882f73b72175ad4","vip":1,"crmLevel":7,"crmLevelSwitch":0,"authorIdStr":"3566095201042840","idStr":"3566095201042840"},"htmlText":"[LOL]&nbsp;","listText":"[LOL]&nbsp;","text":"[LOL]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/698903278","repostId":1122468807,"repostType":4,"repost":{"id":"1122468807","kind":"news","pubTimestamp":1640268939,"share":"https://ttm.financial/m/news/1122468807?lang=&edition=fundamental","pubTime":"2021-12-23 22:15","market":"us","language":"en","title":"Zynex acquires Kestrel Labs for $31M","url":"https://stock-news.laohu8.com/highlight/detail?id=1122468807","media":"seekingalpha","summary":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring t","content":"<p>Zynex(NASDAQ:ZYXI)has&nbsp;acquired&nbsp;100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.</p>\n<p>The transaction closed on December&nbsp;22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.</p>\n<p>ZYXI shares&nbsp;down 1.4% premarket&nbsp;at $10.42.</p>\n<p>Kestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).</p>\n<p>\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.</p>\n<p>Kestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zynex acquires Kestrel Labs for $31M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZynex acquires Kestrel Labs for $31M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZYXI":"Zynex, Inc."},"source_url":"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1122468807","content_text":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.\nZYXI shares down 1.4% premarket at $10.42.\nKestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).\n\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.\nKestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":9000427683,"gmtCreate":1640270908636,"gmtModify":1676533513566,"author":{"id":"3569206984348246","authorId":"3569206984348246","name":"Le66ad","avatar":"https://static.tigerbbs.com/6c476ea553750ec9e5c4f1d349e84eb2","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3569206984348246","idStr":"3569206984348246"},"htmlText":"🤞🏻","listText":"🤞🏻","text":"🤞🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000427683","repostId":1122468807,"repostType":4,"repost":{"id":"1122468807","kind":"news","pubTimestamp":1640268939,"share":"https://ttm.financial/m/news/1122468807?lang=&edition=fundamental","pubTime":"2021-12-23 22:15","market":"us","language":"en","title":"Zynex acquires Kestrel Labs for $31M","url":"https://stock-news.laohu8.com/highlight/detail?id=1122468807","media":"seekingalpha","summary":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring t","content":"<p>Zynex(NASDAQ:ZYXI)has&nbsp;acquired&nbsp;100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.</p>\n<p>The transaction closed on December&nbsp;22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.</p>\n<p>ZYXI shares&nbsp;down 1.4% premarket&nbsp;at $10.42.</p>\n<p>Kestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).</p>\n<p>\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.</p>\n<p>Kestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zynex acquires Kestrel Labs for $31M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZynex acquires Kestrel Labs for $31M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZYXI":"Zynex, Inc."},"source_url":"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1122468807","content_text":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.\nZYXI shares down 1.4% premarket at $10.42.\nKestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).\n\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.\nKestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9000422313,"gmtCreate":1640270175429,"gmtModify":1676533513480,"author":{"id":"3580673378365084","authorId":"3580673378365084","name":"Not_Luke","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3580673378365084","idStr":"3580673378365084"},"htmlText":"Ooooo","listText":"Ooooo","text":"Ooooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000422313","repostId":1122468807,"repostType":4,"repost":{"id":"1122468807","kind":"news","pubTimestamp":1640268939,"share":"https://ttm.financial/m/news/1122468807?lang=&edition=fundamental","pubTime":"2021-12-23 22:15","market":"us","language":"en","title":"Zynex acquires Kestrel Labs for $31M","url":"https://stock-news.laohu8.com/highlight/detail?id=1122468807","media":"seekingalpha","summary":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring t","content":"<p>Zynex(NASDAQ:ZYXI)has&nbsp;acquired&nbsp;100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.</p>\n<p>The transaction closed on December&nbsp;22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.</p>\n<p>ZYXI shares&nbsp;down 1.4% premarket&nbsp;at $10.42.</p>\n<p>Kestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).</p>\n<p>\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.</p>\n<p>Kestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zynex acquires Kestrel Labs for $31M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZynex acquires Kestrel Labs for $31M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZYXI":"Zynex, Inc."},"source_url":"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1122468807","content_text":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.\nZYXI shares down 1.4% premarket at $10.42.\nKestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).\n\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.\nKestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":698046272,"gmtCreate":1640269171009,"gmtModify":1676532436071,"author":{"id":"3582248787663478","authorId":"3582248787663478","name":"kcdc86","avatar":"https://community-static.tradeup.com/news/cc68f682561b677ba318c1b85eb97dee","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"3582248787663478","idStr":"3582248787663478"},"htmlText":"Pls like.. Thanks..&nbsp;","listText":"Pls like.. Thanks..&nbsp;","text":"Pls like.. Thanks..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/698046272","repostId":1122468807,"repostType":4,"repost":{"id":"1122468807","kind":"news","pubTimestamp":1640268939,"share":"https://ttm.financial/m/news/1122468807?lang=&edition=fundamental","pubTime":"2021-12-23 22:15","market":"us","language":"en","title":"Zynex acquires Kestrel Labs for $31M","url":"https://stock-news.laohu8.com/highlight/detail?id=1122468807","media":"seekingalpha","summary":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring t","content":"<p>Zynex(NASDAQ:ZYXI)has&nbsp;acquired&nbsp;100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.</p>\n<p>The transaction closed on December&nbsp;22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.</p>\n<p>ZYXI shares&nbsp;down 1.4% premarket&nbsp;at $10.42.</p>\n<p>Kestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).</p>\n<p>\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.</p>\n<p>Kestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zynex acquires Kestrel Labs for $31M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZynex acquires Kestrel Labs for $31M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZYXI":"Zynex, Inc."},"source_url":"https://seekingalpha.com/news/3783027-zynex-acquires-kestrel-labs-for-31m","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1122468807","content_text":"Zynex(NASDAQ:ZYXI)has acquired 100% of Kestrel Labs, a laser-based, noninvasive patient monitoring technology company.\nThe transaction closed on December 22, 2021 at an approx. value of $31M, consisting of $16M in cash and ~$15M in Zynex common stock.\nZYXI shares down 1.4% premarket at $10.42.\nKestrel Labs' proprietary NiCO CO-Oximeter laser-based photoplethysmography patient monitoring technology identifies, measures, and monitors four crucial species of hemoglobin, which include O2Hb (oxygenated hemoglobin), RHb (reduced hemoglobin), COHb (carboxyhemoglobin), and metHb (methemoglobin).\n\"We will begin integrating Kestrel Labs' two main products into our existing monitoring portfolio and seek regulatory clearance,\" said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex.\nKestrel Labs' laser-based technology allows it to measure distinct parameters, including distinguishing between hemoglobin bound to carbon monoxide rather than to oxygen, which would lead to better quality of care.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7090777,"gmtCreate":1640269591141,"gmtModify":1663239114137,"authorId":3578715828142222,"author":{"id":3578715828142222,"idStr":"3578715828142222","authorId":3578715828142222,"name":"jub","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":698046272,"type":1,"supId":0,"prevId":0,"content":"<u>Ok</u>","text":"<u>Ok</u>","html":"<u>Ok</u>"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":71,"commentSize":7,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}